نتائج البحث 131-140 من 2115 لعملية البحث عن anti-TNF drugs
The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
... drug therapy against pulmonary mycobacterium avium complex (MAC) disease, and whether 2-drug therapy is better tolerated than 3-drug therapy. A Study to ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
... treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes.
... treatment, or cannot be surgically removed. Drugs such as sapanisertib may ... Anti-cancer activity will be assessed every 6 weeks during therapy and ...
Drugs used in chemotherapy, such as paclitaxel ... anti-HER2 therapies, such as trastuzumab ... Drugs used in chemotherapy, such as temozolomide ...
PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ... Drugs used in chemotherapy, such as cisplatin ... treatment in patients with ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies ... Drugs used in chemotherapy, such as cisplatin and ... anti-HER2 ...
Stem cell therapy has emerged as a new paradigm of treatment in the field of CHD with promising results. Cardiac regeneration has been the focus of acquired, ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.